Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells

Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells

Show other versions (1)

Bibliographic Details
Main Authors:	Barnes, E, Salio, M, Cerundolo, V, Medlin, J, Murphy, S, Dusheiko, G, Klenerman, P
Format:	Journal article
Published:	2004

Similar Items

Impact of alpha interferon and ribavirin on the function of maturing dendritic cells.
by: Barnes, E, et al.
Published: (2004)

Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
by: Renneson, J, et al.
Published: (2005)

Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.
by: Salio, M, et al.
Published: (2000)

Lack of dendritic cell maturation by the plant toxin ricin.
by: Smith, D, et al.
Published: (2004)

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.
by: Salio, M, et al.
Published: (2001)

Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.
by: Barnes, E, et al.
Published: (2008)

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
by: Salio, M, et al.
Published: (2004)

Response of Hepatitis C Patients to Alpha Interferon and Ribavirin Combination Therapy
by: Ihsanullah Mahsud, et al.
Published: (2004-06-01)

Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues.
by: Collier, J, et al.
Published: (2001)

Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C
by: Chi-Hsuan Chiang, et al.
Published: (2014-12-01)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
by: Debora Lucia Seguro Danilovic, et al.
Published: (2011-01-01)

Dendritic cells: a journey from laboratory to clinic.
by: Cerundolo, V, et al.
Published: (2004)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, PhD, et al.
Published: (2011-07-01)

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, et al.

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
by: Luis Jesuíno de Oliveira Andrade, et al.

The role of plasmacytoid dendritic cells and interferon-alpha in the immunopathogenesis of psoriasis
by: Rafael Denadai
Published: (2013-01-01)

Basic aspects of the treatment for hepatitis C: mechanisms of action of interferon alpha and ribavirin and the bases of individualization
by: Carlos Eduardo de Melo, et al.

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
by: Yin-Qiu Huang, et al.
Published: (2020-07-01)

Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c
by: BSE August-Jörg, et al.
Published: (2003-08-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01)

Interferon alpha-2b and ribavirin as combined therapy for chronic hepatitis C in Cuba: National Program
by: Hugo Nodarse-Cuní, et al.

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
by: Maryam Keshvari, et al.
Published: (2016-01-01)

Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital.
by: Khalid A. Al-Khazraji
Published: (2017-04-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C
by: T Bischof, et al.
Published: (2007-07-01)

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
by: Juan José Urquijo, et al.
Published: (2013-01-01)

Combination therapy for chronic hepatitis C: interferon and ribavirin.
by: Christie, J, et al.
Published: (1999)

İnterferon ve ribavirin tedavisiyle gelişen plevral efüzyon
by: Aziz Öğütlü, et al.
Published: (2015-09-01)

Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC)
by: Gupta Rahul, et al.
Published: (2012-03-01)

Comparison of Polymerase Chain Reaction before and after Interferon Alpha and Ribavirin Combination Therapy in Chronic Hepatitis C Infection
by: Javed Ahmad Khan
Published: (2012-12-01)

Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.
by: Mark A A Claassen, et al.
Published: (2012-01-01)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

Three Patients with Viral Breakthrough during Pegylated Interferon Alpha-2b and Ribavirin Therapy: A Case Series
by: Daigo Kon, et al.
Published: (2011-01-01)

Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
by: Hamid Kalantari, et al.
Published: (2007-08-01)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
by: Nishikawa Hiroki, et al.
Published: (2012-03-01)

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a brazilian sample
by: Candice Beatriz Treter Gonçalves, et al.
Published: (2012-06-01)

Decrease in regulatory T-cell function in chronic hepatitis C patients receiving pegylated-interferon plus ribavirin
by: Kuo-Chih Tseng, et al.
Published: (2017-05-01)